Pentosan: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 23: | Line 23: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 22:25, 17 March 2025
Pentosan is a medication that is primarily used in the treatment of osteoarthritis. It is classified as a disease-modifying osteoarthritis drug (DMOAD), and it works by improving the health of the joint cartilage. Pentosan is also used in veterinary medicine, particularly for the treatment of osteoarthritis in dogs and horses.
Pharmacology[edit]
Pentosan is a semi-synthetic drug manufactured from beechwood hemicelluloses. It has both anticoagulant and fibrinolytic properties, but its primary mechanism of action in treating osteoarthritis is not fully understood. It is believed to stimulate the synthesis of proteoglycans, which are essential components of the joint cartilage.
Uses[edit]
Pentosan is used in the treatment of osteoarthritis in humans, dogs, and horses. It is administered via injection, and the typical course of treatment involves multiple injections over several weeks. In addition to its use in treating osteoarthritis, pentosan has also been investigated for potential use in treating interstitial cystitis and thrombosis.
Side Effects[edit]
Like all medications, pentosan can cause side effects. The most common side effects include gastrointestinal upset, skin reactions at the injection site, and changes in liver function. In rare cases, pentosan can cause serious side effects such as bleeding complications and liver toxicity.
See Also[edit]
References[edit]
<references />


